MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-JK-21-0009217
Neptune Pharmaceuticals Private Limited
Neptune Pharmaceuticals Private Limited - chemicals in Srinagar, Jammu And Kashmir, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹27.79 Lakh
▲ 28% YoY
Net profit · FY 2025
₹49,340
Net margin 1.8%
EBITDA · FY 2025
₹1.34 Lakh
EBITDA margin 4.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹15 Lakh
Secured borrowings
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
About Neptune Pharmaceuticals Private Limited
Data last updated:
Neptune Pharmaceuticals Private Limited is a private limited company based in Srinagar, Jammu And Kashmir, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 18 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U33309JK2014PTC004151. Its GSTIN is 01AAECN8419R1Z1 (Jammu and Kashmir). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Abdul Qayoom Shah and Tufail Qayoom Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Main Chowk Karan Nagar, Srinagar, Jammu and Kashmir, India – 190001.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.79 Lakh, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹49,340 (net margin 1.8%) and EBITDA of ₹1.34 Lakh (EBITDA margin 4.8%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 12% over five years.
As per MCA filings, the company has open charges of ₹15 Lakh on record.
Neptune Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JK-21-0009217). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U33309JK2014PTC004151
Registration Number 004151
Incorporation Date 18 March 2014
ROC Jammu
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-JK-21-0009217
Recognitions & Rankings of Neptune Pharmaceuticals
Contact details
Neptune Pharmaceuticals Private Limited's registered office is in Srinagar, Jammu And Kashmir. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressMain Chowk Karan Nagar, Srinagar, Jammu and Kashmir, India – 190001
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Neptune Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Neptune Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Neptune Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Neptune Pharmaceuticals Private Limited, buy the company report.
Financials of Neptune Pharmaceuticals Private Limited
FY 2025 filings availableNeptune Pharmaceuticals Private Limited reported revenue of ₹27.79 Lakh (up 28% YoY) for FY 2025.
Revenue · FY 2025
₹27.79 Lakh ▲ 28%
Net profit · FY 2025
₹49,340 margin 1.8%
EBITDA · FY 2025
₹1.34 Lakh margin 4.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▼ 1%
5 years · compounded
▼ 12%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 30%
5 years · compounded
▼ 3%
Revenue rose 28% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 12%. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹49,340 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.8% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neptune Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neptune Pharmaceuticals Private Limited
Neptune Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abdul Qayoom Shah | Director | 16 May 2024 | 2 Years 5 Months | Current |
| Tufail Qayoom Shah | Director | 18 Mar 2014 | 12 Years 7 Months | Current |
Peer comparison
Neptune Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bescheiden Pharmaceuticals Private Limited | ₹28.04 Lakh (FY 2025) | 840.0% | Gmc, Assam, India | |||
| Tangible Pharmaceuticals Private Limited | ₹27.89 Lakh (FY 2025) | -30.0% | Mirzapur, Uttar Pradesh, India | |||
| Neptune Pharmaceuticals Private Limitedthis company | ₹27.79 Lakh (FY 2025) | ₹49,340 | 1.8% | 28.0% | Srinagar, Jammu And Kashmir, India | |
| Rank Pharmaceuticals Limited | ₹27.73 Lakh (FY 2025) | Delhi, India | ||||
| Samvee Pharmaceuticals Private Limited | ₹27.63 Lakh (FY 2022) | 5.0% | Hyderabad, Telangana, India | |||
| Ceedar Pharmaceuticals Private Limited | ₹27.63 Lakh (FY 2025) | -14.0% | Kanpur, Uttar Pradesh, India |
To see the full peer comparison of Neptune Pharmaceuticals Private Limited, buy the company report.
Auditor
Neptune Pharmaceuticals Private Limited is audited by AHM & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AHM & CO | FY 2017 | 500165N |
Shareholding
The shareholding of Neptune Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Neptune Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹15 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Apr 2022 | 100570342 | The Jammu and Kashmir Bank Limited | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Neptune Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neptune Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neptune Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 01AAECN8419R1Z1 | Jammu and Kashmir | Active | 05 Jun 2018 |
| 07AAECN8419R1ZP | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Neptune Pharmaceuticals Private Limited, buy the company report.
Recent activity
Neptune Pharmaceuticals Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Abdul Qayoom Shah was appointed as Director on 16 May 2024.
AGM
Neptune Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Neptune Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jammu.
Appointed
Abdul Qayoom Shah was appointed as Director.
Ceased
Murtaza Shah ceased to be Director.
Charges
A charge with The Jammu And Kashmir Bank Limited amounted to Rs. 15.00 Lakh with Charge ID 100570342 was registered on 30 Apr 2022.
Ceased
Mir Irshad Ahmad ceased to be Director.
Appointed
Tufail Qayoom Shah was appointed as Director.
Incorporation
18 Mar 2014
Neptune Pharmaceuticals Private Limited was registered on 18 Mar 2014 with Roc Jammu & aged 12 years 7 months as per MCA records.
Frequently asked questions
Neptune Pharmaceuticals is an active private limited company based in Srinagar, Jammu And Kashmir, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 18 March 2014 (12+ years old) and is registered under CIN U33309JK2014PTC004151.
Neptune Pharmaceuticals has 2 current directors:
- Abdul Qayoom Shah - Director
- Tufail Qayoom Shah - Director
The latest financial statements of Neptune Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Neptune Pharmaceuticals is 01AAECN8419R1Z1, registered in Jammu and Kashmir. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 07AAECN8419R1ZP (Delhi).
The CIN (Corporate Identification Number) of Neptune Pharmaceuticals is U33309JK2014PTC004151. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neptune Pharmaceuticals was incorporated on 18 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Jammu.
The peers of Neptune Pharmaceuticals by revenue are Bescheiden Pharmaceuticals Private Limited, Tangible Pharmaceuticals Private Limited, Rank Pharmaceuticals Limited, Samvee Pharmaceuticals Private Limited, Ceedar Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Abdul Qayoom Shah was appointed as Director on 16 May 2024. Murtaza Shah ceased to be Director on 16 May 2024. Mir Irshad Ahmad ceased to be Director on 02 Jan 2020. Neptune Pharmaceuticals has 4 board changes on record in total.
Yes, Neptune Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-JK-21-0009217).
The registered office of Neptune Pharmaceuticals is at Main Chowk Karan Nagar, Srinagar, Jammu and Kashmir, India – 190001.
Neptune Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.